DENTSPLY SIRONA Shares Drop on Friday, Underperform Market
January 6, 2023
Trending News 🌥️
DENTSPLY SIRONA ($NASDAQ:XRAY) is a leading global dental technology and equipment provider with a broad portfolio of products and services. The company’s products are used in dentistry and oral health care, including dental implants, dental equipment, orthodontic appliances, prosthetics, and other products. On Friday, DENTSPLY SIRONA shares dropped significantly, lagging behind the overall market. The pandemic has caused many providers to reduce the number of services they offer, leading to decreased demand for DENTSPLY SIRONA’s products and services. In addition to the pandemic-related concerns, investors are also worried about DENTSPLY SIRONA’s ability to compete in a highly competitive dental equipment market.
The company faces stiff competition from several large players, including Straumann and Danaher, and must constantly innovate in order to stay ahead of the competition. Given these issues, it is no surprise that DENTSPLY SIRONA underperformed the overall market on Friday. While the stock may recover in the near term, investors should remain cautious in light of the company’s short-term challenges.
Market Price
The news sentiment for the company is mostly neutral right now. On Tuesday, DENTSPLY SIRONA stock opened at $32.0 and closed at $32.7, up by 2.7% from last closing price of 31.8. Overall, DENTSPLY SIRONA has shown a mixed performance in the past few weeks, with its shares underperforming the market despite a slight increase in its share price on Tuesday. Going forward, investors will be keeping a close eye on the company’s performance to see if it can turn things around and start to show some improvement in its stock price and fundamentals. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for Dentsply Sirona. More…
| Total Revenues | Net Income | Net Margin |
| 4.06k | -806 | 8.9% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for Dentsply Sirona. More…
| Operations | Investing | Financing |
| 597 | -148 | -290 |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for Dentsply Sirona. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 7.52k | 3.91k | 16.81 |
Key Ratios Snapshot
Some of the financial key ratios for Dentsply Sirona are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 0.7% | 8.0% | -20.7% |
| FCF Margin | ROE | ROA |
| 10.8% | -12.4% | -7.0% |
VI Analysis
Investors who are looking for a company with solid fundamentals and long-term potential should consider DENTSPLY SIRONA. The company has a high health score of 7/10 when it comes to cashflows and debt, indicating that it has the ability to pay off debt and fund future operations. Furthermore, DENTSPLY SIRONA is strong in dividend and profitability, while being weak in growth and assets. The company is classified as a ‘cow’, meaning that it has the track record of paying out consistent and sustainable dividends, which is attractive to many investors. In addition, those looking for a company with a good history of dividend payouts will be pleased to know that DENTSPLY SIRONA has a long track record of paying out dividends to its shareholders. Furthermore, the company is financially sound, with a healthy balance sheet, and has good cashflow. Finally, the company is well positioned to benefit from the current market conditions, as its products are in demand due to the growing popularity of dental treatments. All these factors make DENTSPLY SIRONA an attractive option for investors seeking a reliable company with good fundamentals. More…
VI Peers
In the competitive world of dental equipment manufacturers, Dentsply Sirona Inc. has held its own against some tough competitors. Edwards Lifesciences Corp, Escalon Medical Corp, and Medistim ASA are all companies that produce dental equipment and supplies that compete with Dentsply Sirona Inc.
– Edwards Lifesciences Corp ($NYSE:EW)
Edwards Lifesciences Corp is a medical technology company that specializes in products and technologies for the treatment of cardiovascular diseases. The company’s market capitalization is $45.45 billion as of 2022, and its return on equity is 18.9%. Edwards Lifesciences is headquartered in Irvine, California, and has operations in more than 75 countries worldwide.
– Escalon Medical Corp ($OTCPK:ESMC)
Escalon Medical Corp is a medical device company that manufactures and markets products for the ophthalmology, optometry, and veterinary markets worldwide. It has a market cap of 800.11k as of 2022 and a return on equity of 1.57%. The company’s products include ophthalmic surgical instruments, intraocular lenses, contact lenses, and disposables.
– Medistim ASA ($BER:MD1)
Medistim ASA is a Norwegian medical device company that develops, manufactures, and markets products for use in cardiac and vascular surgery. The company has a market capitalization of 455.95 million as of 2022 and a return on equity of 24.86%. Medistim’s products are used in a variety of procedures, including coronary artery bypass graft surgery, valve replacement surgery, and endovascular surgery. The company’s products are sold in over 50 countries worldwide.
Summary
Investors of DENTSPLY SIRONA had a difficult Friday, as shares of the company dropped significantly and underperformed the market. Analysts are providing mixed opinions when it comes to the stock, with some bullish and some bearish. The current news sentiment surrounding the company is mostly neutral, so investors should carefully consider the risk-reward ratio before making any decisions.
Overall, investors should pay attention to macroeconomic conditions, industry trends, competitive landscape, and other factors before investing in DENTSPLY SIRONA. Fundamental analysis of the company’s financial statements and other information will provide a better understanding of the stock’s performance and whether or not it is a worthwhile investment.
Related Posts
Recent Posts
Investing Everyone Can Do.
Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.
